NEWLINK GENETICS
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.
NEWLINK GENETICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
1999-01-01
Address:
Ames, Iowa, United States
Country:
United States
Website Url:
http://www.newlinkgenetics.com
Total Employee:
51+
Status:
Active
Contact:
(515) 598-2928
Email Addresses:
[email protected]
Total Funding:
33.59 M USD
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Google Maps Google Maps API DigiCert SSL Google Maps For Work GeoTrust SSL
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Eureka Genomics
Eureka Genomics develops diagnostics to detect inherited genetic traits, cancers, and infectious diseases in humans, animals, and crops.
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Iowa Capital Management
Iowa Capital Management investment in Series C - NewLink Genetics
Chicagoland Investors
Chicagoland Investors investment in Series C - NewLink Genetics
Ames Seed Capital
Ames Seed Capital investment in Series C - NewLink Genetics
Midwest Oilseeds
Midwest Oilseeds investment in Series C - NewLink Genetics
NLG Advisors
NLG Advisors investment in Series C - NewLink Genetics
Iowa Capital Management
Iowa Capital Management investment in Series B - NewLink Genetics
Midwest Oilseeds
Midwest Oilseeds investment in Series B - NewLink Genetics
Ames Seed Capital
Ames Seed Capital investment in Series B - NewLink Genetics
NLG Advisors
NLG Advisors investment in Series B - NewLink Genetics
Official Site Inspections
http://www.newlinkgenetics.com
Unable to get host informations!!!
More informations about "NewLink Genetics"
NewLink Genetics - Crunchbase Company Profile & Funding
NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases. View contacts for NewLink Genetics to access …See details»
NewLink Genetics and Lumos Pharma Enter into Merger …
Merck and NewLink Genetics Enter Into Licensing and …
Nov 24, 2014 · NewLink is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology products to improve treatment options for patients …See details»
NewLink Genetics - LinkedIn
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer.See details»
Newlink Genetics Company Profile 2024: Valuation, …
Newlink Genetics was founded in 1999. Where is Newlink Genetics headquartered? Newlink Genetics is headquartered in Ames, IA. What industry is Newlink Genetics in? Newlink Genetics’s primary industry is Laboratory …See details»
Lumos Pharma acquires NewLink Genetics - 2019-09-01
Acquiring Organization: Lumos Pharma Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency. Announced …See details»
NewLink Genetics and Lumos Merge to Focus on Rare Disease …
Oct 1, 2019 · NewLink Genetics and Lumos Pharma have agreed to merge to form a new company focused on developing therapies to treat patients with rare diseases.See details»
Lumos Pharma, Inc. completed the acquisition of NewLink …
Mar 17, 2020 · Lumos Pharma, Inc. entered into an agreement to acquire NewLink Genetics Corporation in a reverse merger transaction on September 30, 2019.See details»
NewLink Genetics Company Profile - Office Locations ... - Craft
Mar 18, 2020 · NewLink Genetics Corporation (NewLink) is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for …See details»
NewLink Genetics Reports Fourth Quarter and Full Year 2019 …
Dec 19, 2019 · NewLink Genetics is a clinical-stage biopharmaceutical company that has historically focused on developing novel immunotherapeutic products for the treatment of …See details»
NewLink's two-decade run ends in reverse merger, layoffs
Oct 1, 2019 · NewLink Genetics will combine with privately held Lumos Pharma, announcing Tuesday a reverse merger that fuses the two companies' management teams and give Lumos …See details»
NewLink Genetics Provides Corporate Update and Reports Second …
The Investor Relations website contains information about Lumos Pharma's business for stockholders, potential investors, and financial analysts.See details»
NewLink Genetics Corporation Announces Project to Develop New …
Feb 2, 2016 · The Investor Relations website contains information about Lumos Pharma's business for stockholders, potential investors, and financial analysts.See details»
NewLink Genetics to Merge With Lumos Pharma - WSJ
Sep 30, 2019 · NewLink Genetics Corp. has agreed to merge with Lumos Pharma Inc. in a stock swap.See details»
NewLink Genetics Announces Exclusive Worldwide License
Dec 23, 2019 · NewLink Genetics is a clinical-stage biopharmaceutical company that has historically focused on developing novel immunotherapeutic products for the treatment of …See details»
Genentech pays $150M upfront to partner on NewLink's immuno …
Oct 20, 2014 · Biotech powerhouse Genentech is going all in with Ames, IA-based NewLink Genetics, partnering on an early-stage cancer program which has been billed as an important …See details»
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 …
Sep 4, 2014 · NewLink Genetics Corporation today announced that the United States Food and Drug Administration has given permission for the Company to proceed to Phase 1 clinical trials …See details»
NewLink Genetics Corp.
Part 1 is a randomized single ascending dose study of indoximod salt formulation to characterize the PK profile and determine the safety and tolerability of each dose in healthy male …See details»
NewLink Genetics: Explicating The Changing Fundamentals Of A …
May 17, 2018 · Based in Ames IA, NewLink Genetics is focusing on the therapeutic innovation and commercialization to service highly difficult-to-manage cancers. In harnessing the power …See details»
The Ebola vaccine underdog | Science - AAAS
Oct 28, 2014 · In the race to develop an Ebola vaccine, little NewLink Genetics has been in the shadow of pharmaceutical giant GlaxoSmithKline (GSK). Both companies have rushed …See details»